The inhibition of FAK reduces ECM deposition and the stiffness of cancer cells, thus promoting the penetration of the LNPs in tumoral ECM and their internalization in cancer cells, while inhibiting immune checkpoint. This evidence concerns the gene PTK2 and cancer.